🇺🇸 FDA

Company profile · Sponsor

Cipla

Cipla Australia Pty Ltd

E3EA63B · TGA pharma AU
Pipeline
0
Drugs
6
Patents
0

Quick answer

Cipla (E3EA63B) is a pharma company. headquartered in AU. listed on TGA. NovaPharmaNews links 0 pipeline programs, 6 drugs, and 0 patents to this profile..

Company facts

Ticker E3EA63B
Exchange TGA
Company type pharma
Headquarters AU

Pipeline (0)

No pipeline programs linked yet.

Drugs (6)

Search drugs →

  1. beclometasone + formoterol

    FOSTAIR

  2. budesonide + formoterol

    SYMBICORT RAPIHALER 100/3

  3. gefitinib

    CIPLA GEFITINIB

    ORAL approved

    L01XE02

  4. icatibant

    CIPLA ICATIBANT

    B06AC02

  5. ipratropium

    ATROVENT

  6. tenofovir disoproxil + emtricitabine

    CIPLA TENOFOVIR + EMTRICITABINE 300/200

Frequently asked questions

What is Cipla?

Cipla (E3EA63B) is a pharma company. headquartered in AU. listed on TGA. NovaPharmaNews links 0 pipeline programs, 6 drugs, and 0 patents to this profile..

Does Cipla have pipeline programs in our database?

No pipeline programs are currently linked to Cipla. Programs may be added as ClinicalTrials.gov sponsor matching improves — check back or search the global pipeline directory.

Where does Cipla company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.